| Jul 18 |
Abbott Makes A Bearish Move Despite 'Clean Print' That Includes A Guidance Boost
|
| Jul 18 |
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth
|
| Jul 18 |
Compared to Estimates, Abbott (ABT) Q2 Earnings: A Look at Key Metrics
|
| Jul 18 |
Abbott raises 2024 outlook after MedTech strength in Q2
|
| Jul 18 |
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
|
| Jul 18 |
Abbott Laboratories in charts: Medical Devices maintains Y/Y double-digit growth momentum in Q2
|
| Jul 18 |
Earnings Summary: Abbott Laboratories tops consensus in Q2, raises FY2024 EPS outlook
|
| Jul 18 |
Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.4B beats by $30M
|
| Jul 18 |
Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance
|
| Jul 18 |
2 Dividend Stocks to Buy and Hold Forever
|
